Aboelnaga, Mohamed M <br/><br/>
Different Cabergoline Effect on Metabolic and Anthropometric Parameters in Female Prolactinoma Patients Versus Idiopathic Hyperprolactinemia Patients.  [electronic resource] 

 -  Endocrine, metabolic & immune disorders drug targets  2019 
 - 511-518 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>2212-3873 
<br/><br/><label>Standard No.: </label>10.2174/1871530319666190219103812  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anthropometry--methods<br/>Body Weight--drug effects<br/>Cabergoline--pharmacology<br/>Dopamine Agonists--pharmacology<br/>Female<br/>Humans<br/>Hyperprolactinemia--drug therapy<br/>Insulin Resistance--physiology<br/>Metabolome--drug effects<br/>Middle Aged<br/>Prolactinoma--drug therapy<br/>Treatment Outcome<br/>Waist Circumference--drug effects<br/>Young Adult